Yuri Furusawa

National Institute of Infectious Diseases

Also affiliated with National Center for Global Health and Medicine

MedicineAgricultural and Biological Sciences

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 7 papers. Top paper: “Characterization and antiviral susceptibility of SARS-CoV-2 Omicron BA.2”.

Characterization and antiviral susceptibility of SARS-CoV-2 Omicron BA.2

Nature(2022)10.1038/s41586-022-04856-1

N/A

10.7DataRank · unranked

293 citations

Maki Kiso, Shun Iida, Masaki Imai, Emi Takashita, Makoto Kuroda +64 more

Characterization of SARS-CoV-2 Omicron BA.4 and BA.5 isolates in rodents

Nature(2022)10.1038/s41586-022-05482-7

N/A

0DataRank · unranked

110 citations

Peter Halfmann, Shun Iida, Seiya Yamayoshi, Yuri Furusawa, Maki Kiso +21 more

Characterization of a new SARS-CoV-2 variant that emerged in Brazil

Proceedings of the National Academy of Sciences(2021)10.1073/pnas.2106535118

N/A

0DataRank · unranked

87 citations

Peter Halfmann, Seiya Yamayoshi, Kiyoko Iwatsuki‐Horimoto, S. Chiba, Tokiko Watanabe +54 more

Characterization of SARS-CoV-2 Omicron BA.2.75 clinical isolates

bioRxiv (Cold Spring Harbor Laboratory)(2022)10.1101/2022.08.26.505450

N/A

0DataRank · unranked

8 citations

Shun Iida, Peter Halfmann, Seiya Yamayoshi, Yuichiro Hirata, Kiyoko Iwatsuki‐Horimoto +25 more

Structural and virologic mechanism of the emergence of resistance to M pro inhibitors in SARS-CoV-2

Proceedings of the National Academy of Sciences(2024)10.1073/pnas.2404175121

N/A

0DataRank · unranked

15 citations

Haydar Bulut, Hironori Hayashi, Naoki Kishimoto, Nobutoki Takamune, Kazuya Hasegawa +10 more

An orally available P1′-5-fluorinated Mpro inhibitor blocks SARS-CoV-2 replication without booster and exhibits high genetic barrier

PNAS Nexus(2024)10.1093/pnasnexus/pgae578

N/A

0DataRank · unranked

9 citations

Haydar Bulut, Hironori Hayashi, Kohei Tsuji, Hiromi Ogata-Aoki, Maki Kiso +23 more

Therapeutic efficacy of monoclonal antibodies and antivirals against SARS-CoV-2 Omicron BA.1 in Syrian hamsters

Nature Microbiology(2022)10.1038/s41564-022-01170-4

N/A

0DataRank · unranked

39 citations

Maki Kiso, Masaki Imai, Seiya Yamayoshi, Mutsumi Ito, Seiichiro Fujisaki +10 more